Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
McKesson
Healthtrust
Cipla
Chinese Patent Office
Mallinckrodt
US Army
Moodys
Chubb
Queensland Health

Generated: January 22, 2018

DrugPatentWatch Database Preview

CODRIX Drug Profile

« Back to Dashboard

Which patents cover Codrix, and what generic alternatives are available?

Codrix is a drug marketed by Watson Labs Florida and is included in three NDAs.

The generic ingredient in CODRIX is acetaminophen; codeine phosphate. There are sixty-six drug master file entries for this compound. Fifty-six suppliers are listed for this compound. Additional details are available on the acetaminophen; codeine phosphate profile page.
Summary for CODRIX
Drug patent expirations by year for CODRIX

US Patents and Regulatory Information for CODRIX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs Florida CODRIX acetaminophen; codeine phosphate TABLET;ORAL 040447-001 Feb 26, 2003 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs Florida CODRIX acetaminophen; codeine phosphate TABLET;ORAL 040441-001 Mar 27, 2003 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs Florida CODRIX acetaminophen; codeine phosphate TABLET;ORAL 040488-001 Mar 28, 2003 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
Argus Health
Cantor Fitzgerald
Mallinckrodt
Boehringer Ingelheim
Merck
Cerilliant
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot